Home > Cardiology > Support for dilated-cardiomyopathy screening in affected families

Support for dilated-cardiomyopathy screening in affected families


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Journal
JAMA
Reuters Health - 01/02/2022 - A new analysis shows that family members of patients with idiopathic dilated cardiomyopathy (DCM) have a "substantial" lifetime risk of developing the condition, supporting a role for family-based DCM screening, researchers say. "For the first time, this study gives us hard numbers on how to counsel family members on their risk of developing DCM, and especially so for family members of Black patients with DCM," Dr. Ray Hershberger of The Ohio State University Wexner Medical Center, in Columbus, told Reuters Health by email. "The lifetime risk of DCM is at least one in five for family members of patients with DCM, and is higher in Black families. So the guidelines, that with a diagnosis of DCM, family members need to undergo clinical screening, should be followed," Dr. Hershberger said. DCM is the chief cause of clinical heart failure, a leading indication for heart transplant. DCM has long been observed to run in families, sugges...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on